PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China flag China · Delayed Price · Currency is CNY
30.80
+0.02 (0.07%)
Sep 1, 2026, 4:00 PM EDT

SHE:301230 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
38.2634.2917.0837.6267.1873.58
Depreciation & Amortization
52.1651.1849.0735.5328.424.07
Other Amortization
43.8743.2828.57139.262.68
Loss (Gain) From Sale of Assets
-0.04-0.04--0.01--0.05
Asset Writedown & Restructuring Costs
1.820.30.290.710.072.55
Loss (Gain) From Sale of Investments
-15.31-7.1-8.41-6.21-0.5-1.8
Provision & Write-off of Bad Debts
1.274.111.270.3-0.312.46
Other Operating Activities
20.5618.263.8318.13-0.774.25
Change in Accounts Receivable
52.83-16.797.11-51.12-8.99-60.22
Change in Inventory
-31.54-16.89-4.37-18.29-6.3713.39
Change in Accounts Payable
7.0234.337.25-7.84-1.7733.55
Change in Other Net Operating Assets
6.736.12-5.411.4511.45
Operating Cash Flow
168.1135.5180.8620.8699.29105.12
Operating Cash Flow Growth
18.48%67.58%287.68%-78.99%-5.55%93.06%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-65.67-43.32-109.4-248.27-123.97-92.12
Sale of Property, Plant & Equipment
0.120.120.150.01-0.06
Investment in Securities
12.76-0.361-339.97-7.991.8
Other Investing Activities
11.720.113.445.940.15-
Investing Cash Flow
-41.07-43.39-44.82-582.28-131.81-90.25

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-25.6619.6515.9112.2426.24
Total Debt Issued
10.7525.6619.6515.9112.2426.24
Short-Term Debt Repaid
--25.66-25.56-10-24.55-26.56
Long-Term Debt Repaid
--25.82-29.34-23.28-14.28-9.39
Lease Payments
-12.07-25.82-29.34-23.28-14.28-9.39
Total Debt Repaid
-37.74-51.49-54.91-33.28-38.84-35.94
Net Debt Issued (Repaid)
-26.99-25.82-35.25-17.37-26.59-9.7
Issuance of Common Stock
3.65---710-
Repurchase of Common Stock
---53.08---
Common Dividends Paid
-69.09-54.04-49.27-38.82-0.78-0.78
Dividends Paid
-69.09-54.04-49.27-38.82-0.78-0.78
Other Financing Activities
-14.71-----
Financing Cash Flow
-107.14-79.87-137.61-56.19682.62-10.48

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-3.271.824.82-0.547.78-2.11
Net Cash Flow
16.6214.07-96.75-618.15657.892.28

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
102.4492.2-28.54-227.41-24.6713.01
Free Cash Flow Growth
167.63%-----37.90%
Free Cash Flow After Leases
90.3666.37-57.88-250.69-38.953.62
Free Cash Flow After Leases Growth
853.04%-----82.72%
Free Cash Flow Margin
14.63%13.39%-5.24%-46.44%-5.15%2.90%
Free Cash Flow Per Share
0.550.50-0.15-1.26-0.170.10
Levered Free Cash Flow
72.7551.38-136.91-130.96-48.28-7.85
Unlevered Free Cash Flow
75.2656.56-131.11-127.54-45.29-6.26

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
9.379.015.17-2.53-4.4311.2
Change in Working Capital
25.51-8.77-10.84-78.22-4.02-2.61